New Baby Powder Lawsuit Filed In California

The new Johnson & Johnson's talcum powder lawsuit, filed on February 6, alleges the health care company did not properly warn the plaintiff of studies linking their product to ovarian cancer.

Wednesday, March 8, 2017 - A new talcum powder ovarian cancer lawsuit was filed in California on February 6, claiming that Johnson & Johnson did not adequately warn consumers of the dangers the connections between their talcum powder products and ovarian cancer. While not one of the main hubs where talcum powder lawsuits are being filed nationwide, California has seen a growing number of claims filed in the state against Johnson & Johnson for the company's involvement in cancer diagnoses related to their popular cosmetic product.

The baby powder lawsuit is similar to many that have been field around the country claiming that Johnson & Johnson had been aware of the ties between their talcum powder products and failed to warn consumers of the actions that could have been taken to avoid an increased risk in contracting ovarian cancer. Talcum powder lawyers on both sides have been battling over these allegations for years, with the plaintiffs receiving nearly $200 million in damages thus far. Juries has not been able to see past the mountain of evidence against Johnson & Johnson proving they were aware of the medical studies proving a link between talcum powder and ovarian cancer.

There are more than 20 of those medical studies that have discovered a positive correlation between talcum powder and ovarian cancer, and most of these have been presented as evidence in a number of trials held over the allegations. Doctors and scientists have shown how talc particles can travel up the fallopian tubes of a woman and become embedded in their ovarian tissues, leading to swelling. This swelling can in turn become the catalyst for the development of ovarian cancer, and this is how the increased risk is passed on to a woman who uses talcum powder for genital hygiene. The risk involved with this process is what has led to more than 2,000 talcum powder ovarian cancer lawsuits nationwide.

In 2017, there are a number of further Johnson & Johnson's baby powder lawsuit trials scheduled which will go a long ways in determining the fate of the allegations and the potential for a lump sum settlement given from Johnson & Johnson to plaintiffs who claim they have been affected by their products. Johnson & Johnson has continued to maintain their innocence throughout the litigative process, and their baby powder attorneys have been able to secure smaller victories in the proceedings. However, the overwhelming momentum remains on the side of the plaintiffs.

The 2,000 talcum powder lawsuits are only expected to grow as more talcum powder lawsuit news continues to come to the public's attention in the wake of the lawsuits. There have also been reverberations of these results worldwide, where Johnson & Johnson's talcum powder products have received increased scrutiny abroad as well as in the U.S. To date, there does not seem to be any indication of a domestic lump sum settlement, through 2017 could be the year that tips the balance irreversibly in the direction of the plaintiffs. Lawsuits like the one filed in California are certainly hoping for such a result.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.